Newsroom
Sorted by: Latest
-
Lyten Launches a New Motorsports Venture to Bring Ultra Lightweight, High Strength 3D Graphene Supermaterials to Automotive Racing
SAN JOSE, Calif. & INDIANAPOLIS--(BUSINESS WIRE)--Lyten, the supermaterial applications company and innovator of 3D Graphene, today announced the launch of Lyten Motorsports, a new venture designed to bring Lyten’s material science innovations to motorsports parts. Lyten Motorsports is launching in partnership with INDYCAR Experience, bringing its 25-year experience as a supplier to motorsports circuits around the world. Lyten’s 3D Graphene is a foundational, carbon-based material that can be t...
-
MEMSCAP : DIFFUSION EN DIRECT DE L’ASSEMBLEE GENERALE MIXTE ANNUELLE DU 3 JUIN 2025
GRENOBLE, France--(BUSINESS WIRE)--Regulatory News: MEMSCAP (Euronext Paris : MEMS), fournisseur leader de solutions de capteurs de pression de haute précision et de forte stabilité pour les marchés de l’aéronautique et du médical, utilisant la technologie des MEMS (Micro Electro Mechanical Systems), annonce la diffusion en direct de sa prochaine assemblée générale mixte annuelle. L’assemblée générale mixte annuelle des actionnaires de MEMSCAP (Euronext Paris : MEMS) se tiendra le 3 juin 2025 à...
-
ATNM Deadline: Rosen Law Firm Urges Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between October 31, 2022, and August 2, 2024. Actinium describes itself as a “late-stage biopharmaceutical company that develops targeted radiotherapies.” For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegation...
-
$8.5 Bn Epigenetics Markets, 2021-2024 & 2025-2029 - Increasing Investment in Biomedical Research, Trends Towards Precision Medicine, Growing Interest in Liquid Biopsy - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Epigenetics Market" report has been added to ResearchAndMarkets.com's offering. The global market for epigenetics research tools and reagents, IVDs and therapeutics is expected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029. This report comprehensively analyzes the global market for epigenetics products, research tools and reagents, epigenetic biomarker-based in vitro dia...
-
VistaShares Announces May 2025 Distributions for OMAH and QUSA ETFs
NEW YORK & SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--VistaShares is today announcing May monthly distribution amounts for its OMAH and QUSA ETFs....
-
Bioplastics Industry Report 2025: Sales Data for 2023, Estimates for 2024, Forecasts for 2028, CAGR Projections through 2029, Profiles of BASF, Arkema, LG Chem., Mitsubishi, and LyondellBasell - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Bioplastics Market" report has been added to ResearchAndMarkets.com's offering. The Bioplastics Market was valued at USD 2.06 trillion in 2024, and is projected to reach USD 5.63 trillion by 2029, rising at a CAGR of 18.3%. Global market volume is estimated to increase from 2,431.9 kilotons in 2024 to reach 5,634.6 kilotons by 2029, at a compound annual growth rate (CAGR) of 18.3% from 2024 through 2029. This report will include details regarding various raw materi...
-
Deadline Approaching: MicroStrategy Incorporated (MSTR) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming July 15, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased MicroStrategy Incorporated d/b/a Strategy (“Strategy” or the “Company”) (NASDAQ: MSTR) securities between April 30, 2024 and April 4, 2025, inclusive (the “Class Period”). MICROSTRATEGY INCORPORATED (MSTR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES F...
-
LICT Corporation Reports 2025 First Quarter Results
RYE, N.Y.--(BUSINESS WIRE)--LICT Corporation (“LICT” or the “Company”; OTC Pink®: LICT) reports financial results for the quarter ended March 31, 2025. Total revenues for the first quarter of 2025 increased by $1.1 million, or 3.3%, to $34.6 million, compared to $33.5 million in the same quarter of 2024. Non-regulated revenues for the first quarter of 2025 increased by $900,000, or 4.9%, to $19.4 million, compared to $18.5 million in the prior year’s first quarter, driven by higher sales of bro...
-
India Wind Power Markets, FY 2024 and Forecasts 2025-2030 - Reduced Tariffs Propel Investments, Generation Based Incentive Program Boosts Wind Energy Initiatives - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Wind Power Market in India (2025-2030)" report has been added to ResearchAndMarkets.com's offering. In FY 2024, the cumulative installed wind power capacity in India stood at 48.16 GW and is expected to reach 89.49 GW by FY 2030, expanding at a compound annual growth rate (CAGR) of ~11.26% during the 2025 - 2030 period. The wind power market in India relates to the industry focused on generating, installing, and distributing electricity via wind power. The wind pow...
-
Emera Inc. Announces Election of Directors
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Inc. (TSX: EMA) announced that at its Annual Meeting of Shareholders held on May 22, 2025, on a vote by ballot, each of the 12 nominees proposed as Directors and listed in its Management Information Circular dated as of March 19, 2025, were elected as Directors. The detailed results of the vote for the election of Directors are set out below. Nominee Votes For Votes Withheld Number Percent Number Percent Scott C. Balfour 142,556,068 99.68% 450,675...